Assura PLC Additional Listing (0769S)
July 12 2022 - 2:00AM
UK Regulatory
TIDMAGR
RNS Number : 0769S
Assura PLC
12 July 2022
12 July 2022
Assura plc
Additional Listing
Assura plc ("Assura" or "the Company"), the UK's leading primary
care property investor and developer, today announces that 974,245
New Ordinary Shares (the "New Shares") have been issued to the
Assura plc Employee Benefit Trust in order to satisfy the awards
pursuant to the 2019 Performance Share Plan (591,051) and also
restricted share awards pursuant to the Performance Share Plan
(383,194).
Application has therefore been made for the admission of the New
Shares to the Official List of the UK Listing Authority and to
trading on the London Stock Exchange's market for listed securities
("Admission"). The New Shares will rank pari passu with the
Company's existing ordinary shares and Admission is expected to
occur at 8.00am on 13 July 2022.
Following the allotment of the New Shares (and including the
scrip dividend shares also to be issued on 13 July 2022 as
announced 11 July 2022), it is expected that the total number of
shares in issue will be 2,959,198,708 (none of which will be held
in treasury) and that, accordingly, the total number of voting
rights of the Company will be 2,959,198,708.
- ENDS -
For more information, please contact:
Assura plc Tel: 01925 945354
Orla Ball, Company Secretary Email: Investor@assura.co.uk
David Purcell, Investor Relations
Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Warrington, UK - caring for more than 600 primary
healthcare buildings, from which almost seven million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31
March 2022, Assura's portfolio was valued at GBP2,752 million.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
* EPRA is a registered trademark of the European Public Real
Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSGPUPUMUPPGQG
(END) Dow Jones Newswires
July 12, 2022 02:00 ET (06:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Assura (LSE:AGR)
Historical Stock Chart
From Jul 2023 to Jul 2024